inVentiv network ups international footprint

Share this article:
Elaine Ferguson
Elaine Ferguson

InVentiv Health Communications (iMC) expanded its brainpower's reach to include New York and Tokyo, adding to  existing locations in Dallas, Philadelphia, London, Paris, Munich and Shanghai.

The new offices give inVentiv what it calls the “industry's largest global network of experts in peer-to-peer medical and scientific communications.”

IMC parent inVentiv Health has been on a roll of sorts, having combined four digital shops into two this past spring to create GSW/Fueled by Blue Diesel, and Ignite + Palio. The former put GSW/Fueled by Blue Diesel on par with the girth of rivals like Ogilvy CommonHealth, CDM and AbelsonTaylor.

IMC was formed last year by the fusion of three existing inVentiv med-comms agencies, Cadent and Selva in Dallas and Litmus in Europe, and was then bolstered by new agencies and teams in key locations. It provides advisory board strategies, as well as medical content, and creates events that connect physicians, nurses and other HCPs.

Elaine Ferguson, inVentiv global managing director based in London, told MM&M that the network chose New York as a location in order to put medical expertise in close proximity to PR, digital and consulting shops.

Having multiple skill sets within easy reach of clients, as the network has done in Europe, “has brought additional value to clients,” she said. “We can work together as an integrated team.”

As for the Tokyo opening, Ferguson said it builds on inVentiv's presence in the world's second-largest healthcare market. Further, she said a local shop just made sense because, “We've seen medical communications as a key driver for communications business within Japan.”

The Tokyo team's starter project involves working in conjunction with iMC's China office, which won a contract to help a global pharma account learn the local oncology space while providing support at an upcoming oncology meeting.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?